Crossmark

Incretin Dominance and Emerging Mechanisms in Obesity Pharmacotherapy: Insights from 275 Registered Clinical Trials (2019–2024)

Published Online: 2025-09-24

Authors

dos Santos Barbosa, Lucas Antônio

Almarie, Bassel

Moreira, Eduardo Luiz Gasnhar
License Information

Text and Data Mining valid from 2025-09-24

Version of Record valid from 2025-09-24
More Information

Article History

Received: 6 June 2025

Accepted: 11 September 2025

First Online: 24 September 2025

Declarations

:

: The authors declare no competing interests.

Document is current